Literature DB >> 2141049

Structural and functional correlation of the human complement receptor type 1.

W W Wong1.   

Abstract

Human CR1 is widely distributed in the circulation as a surface receptor as well as in soluble form in the plasma. It mediates a variety of functions that include phagocytosis and regulation of the complement cascade. This receptor has been cloned and the primary structure reveals that the cell-bound molecule is an integral membrane protein with typical transmembrane and cytoplasmic domains. Its extracellular portion is composed entirely of 30 short consensus repeats (SCR) each having 60 to 70 amino acids. This type of motif is the common structural element of the superfamily of complement regulatory and receptor proteins on chromosome 1. The amino-terminal 28 SCR of CR1 is uniquely organized into four tandem long homologous repeats (LHR) with sequence homologies among corresponding SCR as high as 99%. Each LHR encodes approximately 45 kD and each except the one that is proximal to the cell surface contains a separate binding site for C3b or C4b. Analysis of the genomic structure of CR1 reveals that these LHR are results of intragenic duplication of 20- to 30-kb segments of DNA. The structural allotypes of CR1 that vary in the lengths of the polypeptides are encoded by alleles that contain different numbers of LHR. Their predicted structures would have different numbers of C3b binding sites, perhaps resulting in molecules with different capacities to bind immune complexes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2141049     DOI: 10.1111/1523-1747.ep12875150

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  5 in total

Review 1.  CR1 in Alzheimer's disease.

Authors:  Xi-Chen Zhu; Jin-Tai Yu; Teng Jiang; Ping Wang; Lei Cao; Lan Tan
Journal:  Mol Neurobiol       Date:  2014-05-04       Impact factor: 5.590

Review 2.  Membrane proteins that protect against complement lysis.

Authors:  B P Morgan; S Meri
Journal:  Springer Semin Immunopathol       Date:  1994

3.  Initial assessment of the pathogenic mechanisms of the recently identified Alzheimer risk Loci.

Authors:  Patrick Holton; Mina Ryten; Michael Nalls; Daniah Trabzuni; Michael E Weale; Dena Hernandez; Helen Crehan; J Raphael Gibbs; Richard Mayeux; Jonathan L Haines; Lindsay A Farrer; Margaret A Pericak-Vance; Gerard D Schellenberg; Manuel Ramirez-Restrepo; Anzhelika Engel; Amanda J Myers; Jason J Corneveaux; Matthew J Huentelman; Allissa Dillman; Mark R Cookson; Eric M Reiman; Andrew Singleton; John Hardy; Rita Guerreiro
Journal:  Ann Hum Genet       Date:  2013-01-30       Impact factor: 1.670

4.  No Evidence that Knops Blood Group Polymorphisms Affect Complement Receptor 1 Clustering on Erythrocytes.

Authors:  O V Swann; E M Harrison; D H Opi; E Nyatichi; A Macharia; S Uyoga; T N Williams; J A Rowe
Journal:  Sci Rep       Date:  2017-12-19       Impact factor: 4.379

5.  Regulatory Architecture of the RCA Gene Cluster Captures an Intragenic TAD Boundary, CTCF-Mediated Chromatin Looping and a Long-Range Intergenic Enhancer.

Authors:  Jessica Cheng; Joshua S Clayton; Rafael D Acemel; Ye Zheng; Rhonda L Taylor; Sündüz Keleş; Martin Franke; Susan A Boackle; John B Harley; Elizabeth Quail; José Luis Gómez-Skarmeta; Daniela Ulgiati
Journal:  Front Immunol       Date:  2022-06-13       Impact factor: 8.786

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.